Yi-hong Wei

Dr. Yi-hong Wei


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2024 in Medicine
Verified
Journal Article
Open access
SWShao-Feng Mm Wang
Shao-Feng Mm Wang
HZHai-Ying Mm Zhang
Hai-Ying Mm Zhang
HDHao-Jun Mm Dai
Hao-Jun Mm Dai
JGJie Mm Gong
Jie Mm Gong
YWYan Mm Wang
Yan Mm Wang
YWYi-hong Wei
Yi-hong Wei
Type 2 diabetes mellitus (T2DM) is a risk factor for patients with impaired renal function. The onset of T2DM-induced diabetic kidney disease (DKD) is frequently sub-clinical, potentially culminating in end-stage renal disease. In the current study the factors influencing DKD in elderly patients diagnosed with T2DM were determined. A retrospective cohort study was conducted involving patients ≥60 years of age with T2DM from June 2019 to December 2022. The Cockcroft-Gault formula was used to estimate the glomerular filtration rate. The clinical information and biochemical indicators of patients with an estimated glomerular filtration rate (eGFR) < 90 mL/min/1.73m 2 were collected. Patients were grouped based on a 3-year eGFR decline < 15% and ≥ 15%. The differences between the two groups were compared and the factors influencing the 3-year eGFR decline ≥ 15% were analyzed. A total of 242 patients were included, including 154 in the group with a 3-year eGFR decline < 15% and 88 in the group with a three-year eGFR decline ≥ 15%. Univariate logistic regression analysis showed that smoking cigarettes, and triglycerides (TG) and high-density lipoprotein levels were related to a 3-year eGFR decline ≥ 15% ( P = .039, P < .001, and P = .011, respectively). Multivariate logistic regression analysis showed that the TG level was independently related to a 3-year eGFR decline ≥ 15% ( P = .004; OR = 2.316). There was a significant linear relationship between the eGFR decline and TG level ( P = .002). Patients with a TG concentration > 1.7 mmol/L had a more apparent decrease in the eGFR ( P < .05). For elderly patients with T2DM and an eGFR < 90 mL/min/1.73m 2 , the TG level may be an important risk factor for deteriorating renal function that warrants actively intervention.

7 May 2022 in Revista Brasileira de Farmacognosia
Verified
Journal Article
Open access
PDF file
BQBoyong Qiu
Boyong Qiu
MMMeijiao Mao
Meijiao Mao
ZMZilin Ma
Zilin Ma
BDBing Deng
Bing Deng
LSLin Shen
Lin Shen
YWYi-hong Wei
Yi-hong Wei
Doxorubicin, sold under the brand name Adriamycin among others, is an important drug for cancer therapy; however, its use is limited by its cardiotoxicity. Ginsenoside Rg2 is extracted from Panax ginseng C.A.Mey., Araliaceae, which is believed to have cardioprotective properties. However, to date, there have been no reports on whether ginsenoside Rg2 could protect cardiomyocytes against doxorubicin. In this study, we investigated the action and the underlying mechanisms of cardioprotection of ginsenoside Rg2 upon doxorubicin treatment. Cell counting kit-8 was used to determine cell viability; in addition, terminal deoxynucleotidyl transferase–mediated dUTP nick-end labeling staining was used to detect apoptotic cells. Western blotting was used to investigate the relevant pathways. LY294002, a phosphatidylinositol 3-kinase inhibitor, was also used in this study. Ginsenoside Rg2 significantly (p < 0.01) neutralized cardiomyocyte apoptosis induced by doxorubicin in a dose-dependent manner, but this effect was blocked by LY294002. Furthermore, ginsenoside Rg2 upregulated protein kinase B phosphorylation through the phosphatidylinositol 3-kinase/protein kinase B pathway and inhibited p53 expression. These results suggest that ginsenoside Rg2 could attenuate doxorubicin-induced cardiomyocyte apoptosis via the phosphatidylinositol 3-kinase/protein kinase B pathway. Graphical abstract

29 November 2024 in Medicine
Verified
Journal Article
Open access
YSYan Bd Sun
Yan Bd Sun
BHBin Bd Hua
Bin Bd Hua
YBYan Bai
Yan Bai
WZWang Zheng
Wang Zheng
LSLin Shen
Lin Shen
BDBing Deng
Bing Deng
To comprehensively review cardiorenal syndrome (CRS)-related research, this study analyzes its whole landscape and future trends from a bibliometric perspective. Using “cardiorenal syndrome” as the key word, a representative dataset of CRS was constructed in the Web of Science Core Collection (Science Citation Index Expanded) database up to November 2023. VOSviewer (version 1.6.18) and R-Studio (version 1.4) were used to visualize CRS-related author and national collaboration networks, hotspot distribution clustering and historical citation networks. The annual number of publications shows an upward trend, especially since 2009. The United States is the most active country and closely cooperates with European countries. Cardiorenal Medicine is the journal that publishes the most CRS-related research. Urology & Nephrology and Cardiovascular System & Cardiology are the most prominent areas of CRS literature output. The leaders in CRS-related research are Ronco C from Italy and Mccullough PA, from the United States. Combined with keyword co-occurrence, theme evolution, and strategic distribution analysis, it was found that centering on the mechanism of CRS (cardiovascular lesions, venous congestion, and fibrosis), prognosis (transplantation, dialysis, hospitalization, mortality) and cardiac function management (b-type natriuretic peptide, diastolic dysfunction, left ventricular hypertrophy) is a possible research direction for a long time to come. Although CRS has a relatively short history, it has received a lot of attention and is currently enjoying a high level of overall acceptance. In conclusion, this study explores the major research areas, frontiers and trends in CRS, which are important for future research.

1 May 2024 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
BQBoyong Qiu
Boyong Qiu
SQSiyu Qiao
Siyu Qiao
XSXiujuan Shi
Xiujuan Shi
LSLin Shen
Lin Shen
BDBing Deng
Bing Deng
YWYi-hong Wei
Yi-hong Wei
Background: In China, Shen’ge formula (SGF), a Traditional Chinese Medicine blend crafted from ginseng and gecko, holds a revered place in the treatment of cardiovascular diseases. However, despite its prevalent use, the precise cardioprotective mechanisms of SGF remain largely uncharted. This study aims to fill this gap by delving deeper into SGF’s therapeutic potential and underlying action mechanism, thus giving its traditional use a solid scientific grounding. Methods: In this study, rats were subjected to abdominal aortic constriction (AAC) to generate pressure overload. Following AAC, we administered SGF and bisoprolol intragastrically at specified doses for two distinct durations: 8 and 24 weeks. The cardiac function post-treatment was thoroughly analyzed using echocardiography and histological examinations, offering insights into SGF’s influence on vital cardiovascular metrics, and signaling pathways central to cardiac health. Results: SGF exhibited promising results, significantly enhanced cardiac functions over both 8 and 24-week periods, evidenced by improved ejection fraction and fractional shortening while moderating left ventricular parameters. Noteworthy was SGF’s role in the significant mitigation of myocardial hypertrophy and in fostering the expression of vital proteins essential for heart health by the 24-week mark. This intervention markedly altered the dynamics of the Akt/HIF-1α/p53 pathway, inhibiting detrimental processes while promoting protective mechanisms. Conclusion: Our research casts SGF in a promising light as a cardioprotective agent in heart failure conditions induced by pressure overload in rats. Central to this protective shield is the modulation of the Akt/HIF-1α/p53 pathway, pointing to a therapeutic trajectory that leverages HIF-1α promotion and p53 nuclear transport inhibition.

27 May 2025 in Archives of Medical Science
Verified
Journal Article
Open access
LMLianghao Ma
Lianghao Ma
LDLishan Ding
Lishan Ding
ZXZuoying Xing
Zuoying Xing
HRHongjie Ren
Hongjie Ren
JWJingjing Wei
Jingjing Wei
YWYongxia Wang
Yongxia Wang
Introduction: Inflammatory bowel disease (IBD) includes Crohn’s disease (CD) and ulcerative colitis (UC). Epidemiological studies have found that patients with IBD are more likely to suffer from cardiovascular diseases (CVDs) than the general population. However, so far, no exact causal association has been demonstrated between IBD and CVDs, and more research is needed to clarify this relationship.Material and methods: The two-sample Mendelian randomization (MR) method was used to explore the causal effect of IBD on CVDs. The exposure factor was IBD, including CD and UC. The outcome was CVDs, including chronic heart failure, atrial fibrillation, coronary heart disease, myocardial infarction and hypertension. The single nucleotide polymorphisms (SNPs) are all from the FinnGen genome-wide association study sample database. The CD samples included 210,300 controls and 807 cases, and the UC samples included 215,806 controls and 2701 cases. The samples included are all European samples. SNPs associated with Crohn’s disease and ulcerative colitis were extracted from the IEUGWAS database and quality control and screening were carried out. Inverse variance weighted (IVW), MR-Egger, weighted median and other methods were used to study the causal relationship between them and CVDs. Finally, Cochrane’s Q test, MR-Egger and the leave-one method were used for sensitivity analysis.Results: In this study, 4 SNPs strongly associated with Crohn’s disease and 12 SNPs strongly associated with ulcerative colitis were screened. The IVW method of genetic prediction revealed a positive correlation between Crohn’s disease and the risk of chronic heart failure (OR =1.02; 95% CI: 1.00–1.04), and there was a positive correlation between ulcerative colitis and the risk of chronic heart failure (OR = 1.03; 95% CI:1.00–1.06). IVW, MR-Egger and weighted median showed that Crohn’s disease and ulcerative colitis were not associated with the risk of atrial fibrillation, coronary heart disease, myocardial infarction or hypertension. Sensitivity analysis showed that the results are robust.Conclusions: Crohn’s disease and ulcerative colitis are associated with an increased risk of chronic heart failure, but they are not associated with the risk of other CVDs.

1 March 2026 in Risk Management and Healthcare Policy
Verified
Journal Article
Open access
PDF file
SWShao-Feng Wang
Shao-Feng Wang
FWFeng Wang
Feng Wang
YWYuan Wang
Yuan Wang
HZHai-Ying Zhang
Hai-Ying Zhang
JLJing-Wen Ling
Jing-Wen Ling
YWYi-hong Wei
Yi-hong Wei
Background: In patients ≥ 60 years with hypertension and type 2 diabetes mellitus, triglyceride-glucose index (TyG), TyG-BMI, uric acid to high-density lipoprotein cholesterol ratio (UHR), atherogenic index of plasma (AIP), single point insulin sensitivity estimator (SPISE Index) and their cumulative averages are linked to rapid kidney function decline (RD). This study aimed to identify the parameter most strongly independently associated with RD. Methods: A retrospective cohort study used electronic records from Shanghai Chuansha Huaxia Community Health Service Center. Consecutive patients ≥ 60 years with both diseases (January 2020–December 2023) were enrolled and divided into RD (n=151) and Non-RD (n=499) groups based on 4-year eGFR trajectory. Results: RD group had higher age, cum TyG, UHR, cum UHR, and cum AIP (all P< 0.05). Multivariable logistic regression showed UHR, cum UHR, and cum AIP were independently associated with RD (P< 0.001, P< 0.001, P=0.015). Cum UHR had the strongest association (AUC=0.724, 95% CI 0.675– 0.773) and non-linear relations with incident RD and absolute eGFR decline. Conclusion: Elevated cum UHR is significantly associated with RD in these patients and may serve as a valuable biomarker for high-risk individual identification.